VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics

9 Apr 2019 - Yahoo News
ISNES, Belgium, April 9, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a nonbinding Memorandum of Understanding ("MOU") through its wholly-owned subsidiary, Belgian Volition SPRL, with Texas A&M University, a member of The Texas A&M University System. Pursuant ...
usx:vnrx

---

VolitionRx Limited Extends Clinical Trial Program in Lung Cancer - PRNewswire

3 Apr 2019 - PRNewswire

usx:vnrx

---

VolitionRx Limited Extends Clinical Trial Program in Lung Cancer

3 Apr 2019 - Yahoo News
ISNES, Belgium, April 3, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has added to its extensive clinical trial program with the execution of a non-binding Memorandum of Understanding, through its wholly-owned subsidiary, Belgian Volition SPRL, to ...
usx:vnrx

---

VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China - PRNewswire

28 Mar 2019 - PRNewswire

usx:vnrx

---

VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China

28 Mar 2019 - Yahoo News
ISNES, Belgium, March 28, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a nonbinding Memorandum of Understanding ("MOU") with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun Long March") with an expectation of negotiating and entering into a binding ...
usx:vnrx

---

VolitionRx Limited to Present at Conferences in March & April 2019

25 Mar 2019 - Yahoo News
ISNES, Belgium , March 25, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Executive Vice President, Investor Relations, Scott Powell , is ...
usx:vnrx

---

VNRX: Initial Product Grade Assay Data is Compelling. Strategy Update On April 9th - Zacks Small Cap Research

21 Mar 2019 - Zacks Small Cap Research

usx:vnrx

---

VNRX: Initial Product Grade Assay Data is Compelling. Strategy Update On April 9th

21 Mar 2019 - Yahoo News
VolitionRx (VNRX) reported Q4 financial results and provided a business update. Timelines have been regularly delayed as the clinical grade assays work their way through the ‘product grade’ validation processes and studies.
usx:vnrx

---

VolitionRx Limited to Present at Conferences in the U.S. Next Week

15 Mar 2019 - Yahoo News
ISNES, Belgium, March 15, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, Mr. Cameron Reynolds, is scheduled to present at two conferences in the U.S. next week. During the conferences, Mr. Reynolds will outline Volition's ...
usx:vnrx

---

VolitionRx strengthens balance sheet in 2018 as Nu.Q blood test notches further advances in cancer-detection trials - Proactive Investors USA & Canada

14 Mar 2019 - Proactive Investors USA & Canada

usx:vnrx

---